▶
Expanding the impact of malaria chemoprevention
With new approaches like seasonal and perennial chemoprevention, and the opportunity to integrate with vaccines and other emerging tools, we’re entering a new phase in malaria prevention. Recent research and country experience have shown what’s possible, but scaling impact requires overcoming key challenges in policy, financing, and delivery.
In this PATH Live Forum, we explored the future of malaria chemoprevention: how strategies are evolving, what we’re learning from implementation, and what’s needed to deliver these tools more widely and equitably.
SPEAKERS
- Dr. Caroline Phiri-Chibawe, Deputy Senior Technical Advisor for PMI REACH Malaria, PATH
- Dr. Jane Achan, Principal Advisor, Malaria Consortium
- Dr. Roly Gosling, Professor of Global Health, LSHTM
- Dr. Junior Voundi Voundi, Chemoprevention Lead, NMCP Cameroon
This event was supported by an unrestricted educational grant from GSK Global Health.
Explore all PATH Live Forums: https://www.path.org/p/path-live-forums/?utm_source=youtube&utm_medium=organic&utm_campaign=event
